Safety Reporting

Expert Meetings

Overview

Timely and accurate safety reporting is critically important in clinical research.

CTTI’s work will help you improve the quality and efficiency of safety reporting, reduce irrelevant reports, and increase adherence to FDA requirements for clinical trials conducted under an investigational new drug application (IND). Three sets of recommendations are available to help you to:

Solutions

Search All

Recommendation Summary

    Recommendations

    Resources

      Related Items

      News

      Case Study

      In Detail